LEAWOOD, Kan., May 7, 2019 /PRNewswire/ -- Aratana
Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company
focused on the development and commercialization of innovative
therapeutics for dogs and cats, plans on presenting at the Stifel
Dental & Veterinary Conference on Wednesday, May 29, 2019 at 8:00 a.m. ET in New
York City.
Interested parties may listen to the webcast live or access the
audio link for up to 90 days after the meeting. Presentation slides
from the conference will also be available in the Aratana Investor
Room.
About Aratana Therapeutics
Aratana Therapeutics is a
pet therapeutics company focused on developing and commercializing
innovative therapeutics for dogs and cats. Our mission is to
successfully develop and deliver best-in-class therapeutics,
provide comprehensive service to veterinarians and serve as a
collaborator of choice for human and animal health companies. We
believe our therapeutics are highly differentiated, resolve
recognizable needs in compelling markets and have therapeutic
profiles superior to the standard of care. For more information,
please visit www.aratana.com.
Contacts
For investor inquires:
Rhonda Hellums
ir@aratana.com
(913) 353-1026
For media inquiries:
Rachel Reiff
media@aratana.com
(913) 353-1050
View original content to download
multimedia:http://www.prnewswire.com/news-releases/aratana-therapeutics-to-present-at-stifel-2019-dental--veterinary-conference-300844569.html
SOURCE Aratana Therapeutics